APA (7th ed.) Citation

Davidson, M. H., McKenney, J. M., Shear, C. L., & Revkin, J. H. (2006). Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels. Journal of the American College of Cardiology, 48(9), 1774-1781. https://doi.org/10.1016/j.jacc.2006.06.067

Chicago Style (17th ed.) Citation

Davidson, Michael H., James M. McKenney, Charles L. Shear, and James H. Revkin. "Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels." Journal of the American College of Cardiology 48, no. 9 (2006): 1774-1781. https://doi.org/10.1016/j.jacc.2006.06.067.

MLA (9th ed.) Citation

Davidson, Michael H., et al. "Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels." Journal of the American College of Cardiology, vol. 48, no. 9, 2006, pp. 1774-1781, https://doi.org/10.1016/j.jacc.2006.06.067.